将症状群引入中医治疗功能性胃肠病症状重叠疗效评价体系  

Adding Symptom Clusters to Chinese Medicine Efficacy Evaluation System for Overlapping Symptoms in Functional Gastrointestinal Disorders

作　　者：肖梦丽 赵迎盼[2] 赵梦杰 谭琴 冀瑾瑾 张慧娥 应佳珂 唐旭东[2] 陆芳[1] XIAO Meng-li;ZHAO Ying-pan;ZHAO Meng-jie;TAN Qin;JI Jin-jin;ZHANG Hui-e;YING Jia-ke;TANG Xu-dong;LU Fang(NMPA Key Laboratory for Clinical Research and Evaluation of Chinese Medicine,Xiyuan Hospital of China Academy of Chinese Medical Sciences,Bejing,100091;Institute of Digestive Disease,Xiyuan Hospital of China Academy of Chinese Medical Sciences,Beijing,100091)

机构地区：[1]中国中医科学院西苑医院中药临床研究与评价重点实验室,北京100091 [2]中国中医科学院西苑医院脾胃病研究所,北京100091

出　　处：《中国中西医结合杂志》2024年第4期492-497,共6页Chinese Journal of Integrated Traditional and Western Medicine

基　　金：中国中医科学院科技创新工程重大攻关项目(No.CI2021A04704)。

摘　　要：功能性胃肠病是中医药治疗的优势病种,其临床诊断及治疗均以症状学为主。功能性胃肠病症状重叠的疗效评价不同于单个功能性胃肠病疾病或单个症状的评价,在中医药治疗功能性胃肠病症状重叠的临床研究中仍缺乏高质量的临床疗效评价工具。症状群指标已在国内外多个临床研究中使用,它既符合中医药治疗功能性胃肠病症状重叠临床实际,又符合现代医学对评价工具的要求。通过阐述症状群的概念、制定方法以及其应用于功能性胃肠病症状重叠的可行性,进而探讨将症状群引入功能性胃肠病症状重叠临床疗效评价体系的可行性,以期为中医药治疗功能性胃肠病症状重叠提供特色的临床疗效评价工具。Functional gastrointestinal disorders(FGIDs)are the dominant diseases treated by Chinese medicine(CM),and its clinical diagnosis and treatment are based on symptomatology.The efficacy evaluation of overlapping gastrointestinal symptoms in FGIDs is different from that of a single disease or a single symptom,and a high-quality clinical efficacy evaluation tool in clinical studies of overlapping symptoms in the treatment of CM is still lacking.The symptom cluster indicator,which is aligned with both the clinical realities of CM treatments for overlapping symptoms in FGIDs and the demands of modern medicine for evaluation instruments,has been used in several clinical studies.By expounding upon the concept of symptom clusters,its formulation methodologies,and the feasibility of the overlapping symptoms of FGIDs,this paper aims to explore the viability of integrating symptom clusters into the clinical efficacy evaluation system of CM treatments for these conditions,so as to develop a characteristic clinical eficacy evaluation tool for CM treatment of overlapping symptoms of FGIDs.

关 键 词：症状群 中医药 功能性胃肠病 症状重叠 疗效评价 

分 类 号：R259[医药卫生—中西医结合]